Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges (Q34544615)

2 August 2017

title

Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges (English)

1 reference

2 August 2017

0 references

0 references

1 reference

Danher Wang

1

1 reference

2 August 2017

Michael Hevey

2

1 reference

2 August 2017

Laure Y Juompan

3

1 reference

2 August 2017

Charles M Trubey

4

1 reference

2 August 2017

Nicholas U Raja

5

1 reference

2 August 2017

Stephen B Deitz

6

1 reference

2 August 2017

Jan Woraratanadharm

7

1 reference

2 August 2017

Min Luo

8

1 reference

2 August 2017

Hong Yu

9

1 reference

2 August 2017

Benjamin M Swain

10

1 reference

2 August 2017

Kevin M Moore

11

1 reference

2 August 2017

John Y Dong

12

1 reference

2 August 2017

language of work or name

English

0 references

publication date

3 July 2006

1 reference

2 August 2017

1 reference

2 August 2017

volume

353

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

324-332

1 reference

The complete nucleotide sequence of the Popp (1967) strain of Marburg virus: a comparison with the Musoke (1980) strain.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Marburg virus vaccines: comparing classical and new approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Inactivated Marburg virus elicits a nonprotective immune response in Rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Marburg hemorrhagic fever in Angola--fighting fear and a lethal pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Emergence and re-emergence of vesicular stomatitis in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Construction, purification and characterization of adenovirus vectors expressing apoptosis-inducing transgenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Variation in the glycoprotein and VP35 genes of Marburg virus strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Isolation and identification of the "Marburg virus"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Marburg-virus disease in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Ebola virus-like particles protect from lethal Ebola virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.033

10.1016/J.VIROL.2006.05.033

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference